X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs WYETH LTD - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD WYETH LTD MERCK LTD/
WYETH LTD
 
P/E (TTM) x 50.9 27.7 183.8% View Chart
P/BV x 7.7 5.3 143.8% View Chart
Dividend Yield % 0.4 1.3 28.9%  

Financials

 MERCK LTD   WYETH LTD
EQUITY SHARE DATA
    MERCK LTD
Dec-16
WYETH LTD
Mar-13
MERCK LTD/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1,0601,044 101.5%   
Low Rs623818 76.2%   
Sales per share (Unadj.) Rs632.4298.6 211.8%  
Earnings per share (Unadj.) Rs45.757.2 79.9%  
Cash flow per share (Unadj.) Rs62.358.4 106.7%  
Dividends per share (Unadj.) Rs11.0017.00 64.7%  
Dividend yield (eoy) %1.31.8 71.6%  
Book value per share (Unadj.) Rs388.8249.5 155.9%  
Shares outstanding (eoy) m16.6022.72 73.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.1 42.7%   
Avg P/E ratio x18.416.3 113.1%  
P/CF ratio (eoy) x13.515.9 84.7%  
Price / Book Value ratio x2.23.7 58.0%  
Dividend payout %24.129.7 81.0%   
Avg Mkt Cap Rs m13,96921,157 66.0%   
No. of employees `0001.60.5 321.7%   
Total wages/salary Rs m1,487400 371.7%   
Avg. sales/employee Rs Th6,631.913,787.4 48.1%   
Avg. wages/employee Rs Th939.2813.0 115.5%   
Avg. net profit/employee Rs Th479.42,643.3 18.1%   
INCOME DATA
Net Sales Rs m10,4986,783 154.8%  
Other income Rs m242353 68.7%   
Total revenues Rs m10,7417,136 150.5%   
Gross profit Rs m1,1351,617 70.2%  
Depreciation Rs m27627 1,035.7%   
Interest Rs m06 0.0%   
Profit before tax Rs m1,1021,938 56.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m343632 54.3%   
Profit after tax Rs m7591,301 58.4%  
Gross profit margin %10.823.8 45.4%  
Effective tax rate %31.132.6 95.5%   
Net profit margin %7.219.2 37.7%  
BALANCE SHEET DATA
Current assets Rs m6,4106,984 91.8%   
Current liabilities Rs m8,8282,056 429.4%   
Net working cap to sales %-23.072.6 -31.7%  
Current ratio x0.73.4 21.4%  
Inventory Days Days5899 58.1%  
Debtors Days Days3824 160.4%  
Net fixed assets Rs m1,406244 575.7%   
Share capital Rs m166227 73.1%   
"Free" reserves Rs m6,2865,441 115.5%   
Net worth Rs m6,4555,668 113.9%   
Long term debt Rs m025 0.0%   
Total assets Rs m8,8287,901 111.7%  
Interest coverage xNM353.3-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.9 138.5%   
Return on assets %8.616.5 52.0%  
Return on equity %11.822.9 51.2%  
Return on capital %17.134.0 50.2%  
Exports to sales %8.30.2 3,795.7%   
Imports to sales %21.036.3 57.9%   
Exports (fob) Rs m86915 5,874.3%   
Imports (cif) Rs m2,2092,465 89.6%   
Fx inflow Rs m95915 6,307.9%   
Fx outflow Rs m2,6122,677 97.6%   
Net fx Rs m-1,653-2,662 62.1%   
CASH FLOW
From Operations Rs m1,070923 115.9%  
From Investments Rs m-750317 -236.6%  
From Financial Activity Rs m-150-481 31.1%  
Net Cashflow Rs m171759 22.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 51.1 101.4%  
Indian inst/Mut Fund % 18.2 11.3 161.1%  
FIIs % 1.0 7.2 13.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 30.4 95.7%  
Shareholders   28,591 21,978 130.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SANOFI INDIA  TORRENT PHARMA  PLETHICO PHARMA  CIPLA  ABBOTT INDIA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Sep 21, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ALEMBIC LTD COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS